by Adel Nagy | Jan 7, 2019 | Blog, Bona Fides, Brexit, FMD
Brexit will definitely make wholesalers review their standard operating procedures (SOPs) to comply with the new laws and regulations. Will have to looking at reviewing of key procedures, documentations and policies to reflect the upcoming changes. What kind of...
by Jackie (née Heneghan) Peck | Jan 2, 2019 | Behind the scenes, Blog, Pharmacy Brands
In this day and age we would hope that medical research and clinical trials would be tightly controlled and effective. In 1994, Altman stated that we should be appalled at the money wasted in shoddy medical research where the sample size was too small to be...
by Jackie (née Heneghan) Peck | Dec 21, 2018 | Blog
With a crazy week where Gatwick was ground to a stand still by a drone and many thousands of passengers pilots and flight crew have had their holiday plans scuppered as a result of a criminals activities, can we really see medicines being delivered by a drone? How can...
by Jackie (née Heneghan) Peck | Dec 10, 2018 | Uncategorized
In this day and age, we would hope that medical research and clinical trials would be tightly controlled and effective. In 1994, Altman stated that we should be appalled at the money wasted in shoddy medical research where the sample size was too...
by Suzanne Hayes | Dec 5, 2018 | Blog
MHRA have confirmed that in the event of a no deal Brexit they will be a stand-alone regulator making decisions and functions with a pragmatic approach to current EU standards. They currently have 51 high priority tasks that still need to be implemented for day...
by Sandeep Lyall | Nov 27, 2018 | Blog
The MHRA GDP Symposium held in London on Monday 19th November 2018 seems to be about the changes forthcoming for one reason or another. Obviously, we all aware of the changes that will be inflicted with Brexit looming over us and the requirements set for FMD. However,...
by Jackie (née Heneghan) Peck | Nov 22, 2018 | Blog
This year’s MHRA GDP Symposium seemed to focus on ‘contract’ RP’s with numerous references being made to them, and the services they offer, throughout the day. The MHRA recommended that prospective RP’s should be reference checked, prior to...
by Jackie (née Heneghan) Peck | Nov 5, 2018 | Blog
All manufacturers must appoint a vendor who has a contract in place with the national medicines verification system provider (NMVO) who in turn must have a contract in place with the European FMD Hub (EMVO). Many of the early adopters of these requirements in...
by Jackie (née Heneghan) Peck | Oct 29, 2018 | Blog
Pros Convenience, the consultation can take place in your own home at any time of day. No time needs to be taken off work to attend the consultation. Treatment can be obtained quicker if required. The service is cheaper to deliver than a face to face consultation....
by Jackie (née Heneghan) Peck | Oct 22, 2018 | Uncategorized
The Home Office has announced that Pregabalin and Gabapentin will be reclassified from a Prescription Only Medicine (POM) to a Schedule 3 Controlled Drug in April 2019. What does this mean for wholesalers and pharmacies? Well for pharmacies, the storage of these two...
